Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Low iron and vitamin D levels are linked to hair loss in women.

Minoxidil helps hair growth and reduces shedding in women.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Adult skin quickly reacts to short-term environmental and internal stress, leading to various skin issues and the need for protective measures.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Intermittent low-dose finasteride works as well as daily use for treating excessive hair growth in women.

The VEGF +405G allele may increase the risk of PCOS in South Indian women.

The research found that MRI and certain hormone levels can help tell apart ovarian tumors from hyperthecosis in postmenopausal women, but tissue analysis is still needed for a definite diagnosis.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Electro-acupuncture may help treat PCOS in rats by changing brain DNA methylation.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.